Home › Alnylam Pharmaceuticals Keeping Multiple High-Potential Programs Moving Forward
 

Keywords :   


Alnylam Pharmaceuticals Keeping Multiple High-Potential Programs Moving Forward

2015-11-14 12:16:55| Biotech - Topix.net

Alnylam has had a summer of discontent as worries about the efficacy and tolerability of a lead drug combine with broader concerns about drug pricing and biotech valuations. Even if revusiran is inferior to Isis's rival compound, a backup compound could more than make up the difference and Alnylam is making broad overall progress with its pipeline.

Tags: multiple forward programs moving

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.06Atlantic Tropical Weather Outlook
29.06Eastern North Pacific Tropical Weather Outlook
28.06What we learned from IT expert at Post Office inquiry
28.06M&S to launch clothing repairs service
28.06Tropical Depression Two Graphics
28.06Tropical Depression Two Public Advisory Number 1
28.06Summary for Tropical Depression Two (AT2/AL022024)
28.06Tropical Depression Two Forecast Advisory Number 1
More »